Variations in antidepressant prescribing practice: Clinical need or market influences?

Pharmacoepidemiology and Drug Safety

Volumn 11, Issue 6, 2002, Pages 515-522

  De Las Cuevas, Carlos ^a,b   Sanz, Emilio J ^a   De La Fuente, Juan A ^b  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

^b Canary Islands Health Service   (Spain)

Author keywords

Antidepressants; Pharmaceutical industry; Pharmacoepidemiology; Prescription

Indexed keywords

AMINEPTINE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CITALOPRAM; CLOMIPRAMINE; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; MAPROTILINE; MELITRACEN; MIANSERIN; MIRTAZAPINE; MOCLOBEMIDE; NEFAZODONE; PAROXETINE; REBOXETINE; SERTRALINE; VENLAFAXINE;

ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DEPRESSION; DRUG CLASSIFICATION; DRUG COST; DRUG INDUSTRY; DRUG MARKETING; DRUG USE; ECONOMIC ASPECT; GENERAL PRACTITIONER; HEALTH CARE NEED; HEALTH SERVICE; HUMAN; HUMAN RELATION; MORBIDITY; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; PSYCHIATRIST; QUALITY CONTROL; QUANTITATIVE ANALYSIS; REIMBURSEMENT; SOCIAL ASPECT; SPAIN;

ANTIDEPRESSIVE AGENTS; COMMUNITY PSYCHIATRY; DRUG UTILIZATION REVIEW; FLUOXETINE; HUMANS; MARKETING; PAROXETINE; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, FAMILY; QUESTIONNAIRES; SERTRALINE;

EID: 0036750688     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/pds.715     Document Type: Article

References (21)

1. Freeling P, Rao BM, Paykel ES, Sireling LI, Burton RH. Unrecognized depression in the general practice. BMJ 1985; 290: 1880-1883.
2. Rosholm JU, Hallas J, Gram LF. Outpatient utilization of antidepressants: a prescription database analysis. J Affect Disord 1993; 27: 21-28.
3. Rosholm JU, Gram LF, Isacsson G, Hallas J, Bergman U. Changes in the pattern of antidepressant use upon the introduction of the new antidepressants: a prescription database study. Eur J Clin Pharmacol 1997; 52: 205-209.
4. Kessler RC, McGonagle KA, Zheo S, Nelson CB, Hughes M. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51: 8-19.
5. Murray CJ, López AD. Regional patterns of disability-free life expecting and disability-adjusted life expectancy: global burden of disease study. Lancet 1997; 349: 1347-1352.
6. Murray CJ, López AD. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 1997; 349: 1498-1504.
7. Balestrieri M, Bragagnoli N, Bellantuono C. Antidepressant drug prescription in general practice: a 6-year study. J Affect Disord 1991; 21: 45-55.
8. Sarturno Hernández PJ. Monitorización del uso de medicamentos para mejorar la calidad de la prescripción. Problemas, métodos e indicadores. ('Monitoring of medicines use to improve the quality of prescription. Problems, methods and indicators'. Atención Primaria 1996; 18: 331-338.
9. Harris CM, Heywood PL, Clayden AD. The Analysis of Prescribing in General Practice: A Guide to Audit and Research. HSMO: London, 1990.
10. Chinburapa V, Larsom, LN, Bruucks M, Draugalis J, Bootman JL, Puto CP. Physician prescribing decisions: the effects of situational involvement and task complexity on information acquisition and decision making. Soc Sci Med 1993; 36: 1473-1482.
11. Bergman U, Popa C, Tomson Y, et al. Drug Utilization 90%-a simple method for assessing the quality of drug prescribing. Eur J Pharmacol 1998; 54: 113-118.
12. WHO. Guidelines for ATC Classification and DDD Assignment. WHO Collaborating Centre for Drug Statistics Methodology: Oslo, Norway, 1999.
13. Murphy E, Dingwall R, Greatbatch D, Parker S, Watson P. Qualitative research methods in health technology assessment: a review of the literature. Health Technol Assess 1998; 2: 1-275.
14. Agency for Health Care Policy and Research. Treatment of depression-newer pharmacotherapies (Evidence Report/Technology Assessment, Number 7, Pub. No. 99-EO14), 1999.
15. Beaumont G. The treatment of depression in primary care. In Critical Issues in the Treatment of Affective Disorders, Langer SZ, et al. (eds). Karger: Basel, 1994; 25-31.
16. Lee D, Bergman U. Studies of drug utilization. In Pharmacoepidemiology (2nd edn), Strom BL (ed.). Wiley: New York, 1994; 379-393.
17. Barceló Colomer E, Grau Bartomeu J, Serre Delcor N, Salgado Pineda M, Marti Diget M, Hidalgo Ortiz M. Prescription inducida, grado de conformidad y ... posibilidad de cambio en Atención Primaria? (Induced prescription and level of agreement and ... Is there a possibility of change in Primary Care?) Atención Primaria 2000; 26: 231-238.
18. McManus P, Mant A, Mitchell PB, Montgomery W, Marley J, Auland ME. Recent trends in the use of antidepressant drugs in Australia 1990-1998. Med J Aust 2000; 173: 458-461.
19. Wazana A. Physician and the pharmaceutical industry. Is a gift ever just a gift?. JAMA 2000; 283: 373-380.
20. Tenery RM. Interactions between physicians and the health care technology industry. JAMA 2000; 283: 391-393.
21. Gilbody S, House A. Variations in psychiatric practice: neither unacceptable nor unavoidable, only under-researched. Brit J Psychiatry 1999; 175: 303-305.